[1]
Sellheyer K. Spiradenoma and cylindroma originate from the hair follicle bulge and not from the eccrine sweat gland: an immunohistochemical study with CD200 and other stem cell markers. Journal of cutaneous pathology. 2015 Feb:42(2):90-101. doi: 10.1111/cup.12406. Epub 2014 Nov 24
[PubMed PMID: 25354097]
[2]
Mahalingam M, Srivastava A, Hoang MP. Expression of stem-cell markers (cytokeratin 15 and nestin) in primary adnexal neoplasms-clues to etiopathogenesis. The American Journal of dermatopathology. 2010 Dec:32(8):774-9. doi: 10.1097/DAD.0b013e3181dafd8c. Epub
[PubMed PMID: 20700038]
[3]
Jordão C, de Magalhães TC, Cuzzi T, Ramos-e-Silva M. Cylindroma: an update. International journal of dermatology. 2015 Mar:54(3):275-8. doi: 10.1111/ijd.12600. Epub 2014 Dec 16
[PubMed PMID: 25515269]
[4]
Löser C, Rütten A, Dippel E. [Cylindromas-rare but striking]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete. 2019 Sep:70(9):677-683. doi: 10.1007/s00105-019-4458-9. Epub
[PubMed PMID: 31428801]
[5]
Albores-Saavedra J, Heard SC, McLaren B, Kamino H, Witkiewicz AK. Cylindroma (dermal analog tumor) of the breast: a comparison with cylindroma of the skin and adenoid cystic carcinoma of the breast. American journal of clinical pathology. 2005 Jun:123(6):866-73
[PubMed PMID: 15899777]
[6]
Chauhan DS, Guruprasad Y. Dermal cylindroma of the scalp. National journal of maxillofacial surgery. 2012 Jan:3(1):59-61. doi: 10.4103/0975-5950.102163. Epub
[PubMed PMID: 23251061]
[7]
Revis P, Chyu J, Medenica M. Multiple eccrine spiradenoma: case report and review. Journal of cutaneous pathology. 1988 Aug:15(4):226-9
[PubMed PMID: 2846662]
Level 3 (low-level) evidence
[8]
Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, Dubois A, Rajan N. CYLD Cutaneous Syndrome. GeneReviews(®). 1993:():
[PubMed PMID: 32298062]
[9]
Schittkowski M, Stropahl G, Timm A, Guthoff R. [Nasolacrimal duct obstruction caused by a cylindroma. Report of an atypical tumor manifestation and review of the literature]. Klinische Monatsblatter fur Augenheilkunde. 2002 Aug:219(8):602-8
[PubMed PMID: 12353178]
[10]
Dubois A, Hodgson K, Rajan N. Understanding Inherited Cylindromas: Clinical Implications of Gene Discovery. Dermatologic clinics. 2017 Jan:35(1):61-71. doi: 10.1016/j.det.2016.08.002. Epub
[PubMed PMID: 27890238]
Level 3 (low-level) evidence
[11]
Dhir G, Makkar M, Suri V, Dubey V. Familial dermal eccrine cylindromatosis with emphasis on histology and genetic mapping. Annals of medical and health sciences research. 2013 Nov:3(Suppl 1):S3-6. doi: 10.4103/2141-9248.121207. Epub
[PubMed PMID: 24349843]
[12]
Rajan N, Andersson MK, Sinclair N, Fehr A, Hodgson K, Lord CJ, Kazakov DV, Vanecek T, Ashworth A, Stenman G. Overexpression of MYB drives proliferation of CYLD-defective cylindroma cells. The Journal of pathology. 2016 Jun:239(2):197-205. doi: 10.1002/path.4717. Epub 2016 Apr 21
[PubMed PMID: 26969893]
[13]
Borik L, Heller P, Shrivastava M, Kazlouskaya V. Malignant cylindroma in a patient with Brooke-Spiegler syndrome. Dermatology practical & conceptual. 2015 Apr:5(2):61-5. doi: 10.5826/dpc.0502a09. Epub 2015 Apr 30
[PubMed PMID: 26114054]
[14]
Rajan N, Burn J, Langtry J, Sieber-Blum M, Lord CJ, Ashworth A. Transition from cylindroma to spiradenoma in CYLD-defective tumours is associated with reduced DKK2 expression. The Journal of pathology. 2011 Jul:224(3):309-21. doi: 10.1002/path.2896. Epub 2011 May 19
[PubMed PMID: 21598248]
[15]
Corda G, Sala A. Cutaneous cylindroma: it's all about MYB. The Journal of pathology. 2016 Aug:239(4):391-3. doi: 10.1002/path.4746. Epub 2016 Jul 11
[PubMed PMID: 27185061]
[16]
Son JH, Choi YW, Cho YS, Byun YS, Chung BY, Cho HJ, Kim HO, Park CW. A Case of Eccrine Spiradenoma: A Rarely Seen Soft Tissue Tumor on the Extensor Surface of Arm. Annals of dermatology. 2017 Aug:29(4):519-522. doi: 10.5021/ad.2017.29.4.519. Epub 2017 Jun 21
[PubMed PMID: 28761313]
Level 3 (low-level) evidence
[17]
Massoumi R, Podda M, Fässler R, Paus R. Cylindroma as tumor of hair follicle origin. The Journal of investigative dermatology. 2006 May:126(5):1182-4
[PubMed PMID: 16484982]
[18]
Gupta P, Dey P, Bal A. Fine needle aspiration cytology of dermal cylindroma. Journal of cytology. 2014 Oct-Dec:31(4):213-4. doi: 10.4103/0970-9371.151137. Epub
[PubMed PMID: 25745290]
[19]
Kaushik S, Siegel D, Niermann K, Newman N. Whole Scalp Radiation Therapy for Recurrent Benign Cylindromas. Case reports in dermatology. 2022 May-Aug:14(2):132-137. doi: 10.1159/000524012. Epub 2022 May 30
[PubMed PMID: 35813839]
Level 3 (low-level) evidence
[20]
Khoury E, Godfrey M, Yeoh CC. Gynaecological cylindroma in association with CYLD gene mutation. Oxford medical case reports. 2022 Jan:2022(1):omab139. doi: 10.1093/omcr/omab139. Epub 2022 Jan 24
[PubMed PMID: 35083054]
Level 2 (mid-level) evidence
[21]
Casale F, Elwood HR, Tchanque-Fossuo CN. Exophytic growth on nasal ala. JAAD case reports. 2022 Jan:19():48-50. doi: 10.1016/j.jdcr.2021.10.035. Epub 2021 Nov 17
[PubMed PMID: 34917724]
Level 3 (low-level) evidence
[22]
Watanabe Y, Mori T, Makino T, Yamamoto T. Giant Vascular Cylindroma in a Case of Brooke-Spiegler Syndrome. Indian dermatology online journal. 2022 Nov-Dec:13(6):792-793. doi: 10.4103/idoj.idoj_33_22. Epub 2022 Oct 12
[PubMed PMID: 36386726]
Level 3 (low-level) evidence
[23]
Bargiel J, Wyszyńska-Pawelec G, Gontarz M, Gąsiorowski K, Marecik T, Szczurowski P, Zapała J. Turban Tumor Syndrome: In Search of a Gold Standard - A Case Report. Skin appendage disorders. 2021 Jun:7(4):326-328. doi: 10.1159/000514855. Epub 2021 Mar 30
[PubMed PMID: 34307484]
Level 3 (low-level) evidence
[24]
Nair SP. Soft pink nodules on the scalp. Indian dermatology online journal. 2015 Sep-Oct:6(5):373-4. doi: 10.4103/2229-5178.164473. Epub
[PubMed PMID: 26500882]
[25]
Manicketh I, Singh R, Ghosh PK. Eccrine cylindroma of the face and scalp. Indian dermatology online journal. 2016 May-Jun:7(3):203-5. doi: 10.4103/2229-5178.182355. Epub
[PubMed PMID: 27294061]
[26]
Luo YY, Chen DG, Ji PZ, Liu B, Yang YL. [Brooke-Spiegler syndrome: report of a case]. Zhonghua bing li xue za zhi = Chinese journal of pathology. 2022 Mar 8:51(3):253-255. doi: 10.3760/cma.j.cn112151-20211228-00939. Epub
[PubMed PMID: 35249296]
Level 3 (low-level) evidence
[27]
Vasenina V, Cibull T, Stadlan N. Brooke-Spiegler Syndrome With Cervical Spine Lesion. Cureus. 2020 Oct 16:12(10):e10982. doi: 10.7759/cureus.10982. Epub 2020 Oct 16
[PubMed PMID: 33209538]
[28]
Davies HR, Hodgson K, Schwalbe E, Coxhead J, Sinclair N, Zou X, Cockell S, Husain A, Nik-Zainal S, Rajan N. Epigenetic modifiers DNMT3A and BCOR are recurrently mutated in CYLD cutaneous syndrome. Nature communications. 2019 Oct 17:10(1):4717. doi: 10.1038/s41467-019-12746-w. Epub 2019 Oct 17
[PubMed PMID: 31624251]
[29]
Merlo G, Pesce M, Borra T, Orejuela I, Pasquali F, Panizza R, Ghiglione M, Grosso F. Malignant eccrine spiradenocylindroma and parotid gland involvement in Brooke Spiegler syndrome. Dermatology reports. 2022 Sep 14:14(3):9418. doi: 10.4081/dr.2022.9418. Epub 2022 Jan 26
[PubMed PMID: 36199911]
[30]
Pal S, Bose K, Sikder M, Chowdhury M. Fine needle aspiration cytology of cylindroma of scalp: A case report. Diagnostic cytopathology. 2016 Dec:44(12):1082-1084. doi: 10.1002/dc.23546. Epub 2016 Jul 26
[PubMed PMID: 27456213]
Level 3 (low-level) evidence
[31]
Kacerovska D, Szepe P, Vanecek T, Nemcova J, Michal M, Mukensnabl P, Kazakov DV. Spiradenocylindroma-like basaloid carcinoma of the anus and rectum: case report, including HPV studies and analysis of the CYLD gene mutations. The American Journal of dermatopathology. 2008 Oct:30(5):472-6. doi: 10.1097/DAD.0b013e31817fb37f. Epub
[PubMed PMID: 18806492]
Level 3 (low-level) evidence
[32]
Kalina P, El-Azhary R. Brooke-spiegler syndrome with multiple scalp cylindromas and bilateral parotid gland adenomas. Case reports in radiology. 2012:2012():249583. doi: 10.1155/2012/249583. Epub 2012 Feb 12
[PubMed PMID: 22606564]
Level 3 (low-level) evidence
[33]
Kim KE, Jeong JY, Park TJ, Kim IH. A Case of Malignant Transformation of Solitary Recurrent Cylindroma on Scalp. Annals of dermatology. 2022 Dec:34(6):478-481. doi: 10.5021/ad.20.118. Epub
[PubMed PMID: 36478431]
Level 3 (low-level) evidence
[34]
Nath AK, Udayashankar C. Multiple facial cylindromas: a case report. Dermatology online journal. 2012 Feb 15:18(2):8
[PubMed PMID: 22398229]
Level 3 (low-level) evidence
[35]
Herzum A, Russo R, Cozzani E, Paudice M, Guadagno A, Parodi A. Multiple rubbery nodules on the scalp. JAAD case reports. 2021 Feb:8():80-82. doi: 10.1016/j.jdcr.2020.12.023. Epub 2021 Jan 5
[PubMed PMID: 33532532]
Level 3 (low-level) evidence
[36]
Thomas LW, Pham CT, Coakley B, Lee P. Treatment of Brooke-Spiegler Syndrome Trichoepitheliomas with Erbium: Yttrium-Aluminum-Garnet Laser: A Case Report and Review of the Literature. The Journal of clinical and aesthetic dermatology. 2020 Jul:13(7):41-44
[PubMed PMID: 32983336]
Level 3 (low-level) evidence
[37]
Iyer PV, Leong AS. Malignant dermal cylindromas. Do they exist? A morphological and immunohistochemical study and review of the literature. Pathology. 1989 Oct:21(4):269-74
[PubMed PMID: 2483749]
[38]
Singh DD, Naujoks C, Depprich R, Schulte KW, Jankowiak F, Kübler NR, Handschel J. Cylindroma of head and neck: review of the literature and report of two rare cases. Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery. 2013 Sep:41(6):516-21. doi: 10.1016/j.jcms.2012.11.016. Epub 2012 Dec 21
[PubMed PMID: 23260808]
Level 3 (low-level) evidence
[39]
Mogaddam MR, Maleki N. Cylindroma of the scalp. Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences. 2015 Sep:20(9):923-4. doi: 10.4103/1735-1995.170638. Epub
[PubMed PMID: 26759583]
[40]
Sicinska J, Rakowska A, Czuwara-Ladykowska J, Mroz A, Lipinski M, Nasierowska-Guttmejer A, Sikorska J, Sklinda K, Slowinska M, Kowalska-Oledzka E, Walecka I, Walecki J, Rudnicka L. Cylindroma transforming into basal cell carcinoma in a patient with Brooke-Spiegler syndrome. Journal of dermatological case reports. 2007 Dec 29:1(1):4-9. doi: 10.3315/jdcr.2007.1.1002. Epub
[PubMed PMID: 21886698]
Level 3 (low-level) evidence